Want to join the conversation?
Life science research company $ILMN reported a decrease in GAAP net income to $104MM or $0.70 per share in 4Q15 compared to $153MM or $1.03 per share in 4Q14 hurt by higher operating expenses. Revenue was $592MM, up 15% from 4Q14 and up 19% on a constant currency basis. Non-GAAP net income was $121MM or $0.81 per share.
Still in yesterday’s $PZZA shock. I thought everyone had more pizza this football season!!
$TSLA stock downgraded to sell from hold by brokerage firm CFRA Research. However, the firm lifted the price target by $35 to $240.
$LB shares have plummeted after a disappointing quarter.